# Intradermal Versus Intramuscular Polio Vaccine Booster in HIV-Infected Subjects

> **NCT01686503** · PHASE2 · COMPLETED · sponsor: **Eastern Virginia Medical School** · enrollment: 231 (actual)

## Conditions studied

- Polio Immunity

## Interventions

- **DRUG:** IPOL (Sanofi Pasteur) inactivated polio vaccine booster dose

## Key facts

- **NCT ID:** NCT01686503
- **Lead sponsor:** Eastern Virginia Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 231 (ACTUAL)
- **Last updated:** 2015-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01686503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01686503, "Intradermal Versus Intramuscular Polio Vaccine Booster in HIV-Infected Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01686503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*